国家医保局发布药代篡改检测报告骗保案例;礼来市值突破万亿美元 | 医药早参

每日经济新闻
Nov 24, 2025

丨 2025年11月24日星期一丨  NO.1国家医保局发布医药代表篡改检测报告骗保案例  11月23日,“国家医保局”微信公众号发文,披露医药代表篡改检测报告骗保案例。中国裁判文书网显示,某医药公司医药代表为追逐个人销售业绩,篡改患者基因检测报告,给不符合用药条件的患者使用肿瘤靶向药,造成医保基金损失,最终以诈骗罪锒铛入狱。  点评:使用肿瘤靶向药需要严格遵循药品说明书规定的适应证以及相关基因...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10